Prognostic value of hemodynamics following treatment initiation in pulmonary arterial hypertension
作者
Jason C. Weatherald,Yochai Adir,Athénaïs Boucly,Laurent Savale,Gérald Simonneau,David Montani,Xavier Jaïs,Marc J.C. Humbert,Denis Chemla,Olivier Sitbon,Philippe Hervé
出处
期刊:The European respiratory journal [European Respiratory Society] 日期:2017-09-01卷期号:: OA1507-OA1507
标识
DOI:10.1183/1393003.congress-2017.oa1507
摘要
Background: The prognostic value of hemodynamic variables after treatment initiation in pulmonary arterial hypertension (PAH) is not well established. Methods: We evaluated incident patients between 2006-2016 with idiopathic, drug and toxin-induced or heritable PAH who had a follow-up right heart catheterization (RHC). The primary outcome was death or lung transplantation. We used stepwise Cox regression and receiver operating characteristic (ROC) analysis to assess variables at first follow-up RHC Results: Of 763 patients, death or transplantation occurred in 211 (27.7%) over a median follow-up time of 3.2 years (IQR25-75% 1.61-5.13). Median time to first follow-up RHC was 4.6 months (IQR 3.7-7.8). Multivariate predictors at first follow-up RHC were: age, male gender, idiopathic PAH, New York Heart Association functional class, 6-minute walk distance, stroke volume index (SVI), and right atrial pressure (RAP). Adjusted hazard ratios for hemodynamic variables were: SVI 0.975 (95%CI 0.961-0.989, p<0.01), and RAP 1.05 (95%CI 1.053-1.086, p<0.01). Optimal cut-points from ROC analysis were: SVI 38 mL/m2 (Area Under the Curve [AUC] 0.68) and RAP 9 mmHg (AUC 0.62). The addition of cardiac index, capacitance index (SVI/pulse pressure) or pulmonary vascular resistance index did not improve prediction. Among patients with cardiac index ≥2.5 L/min/m2 at first follow-up (n=531), those with SVI<38 mL/m2 had a worse prognosis (Log-rank test p<0.01). Conclusions: Stroke volume index and right atrial pressure at first follow-up catheterization were the best hemodynamic predictors of death or transplantation. These variables should be further validated as treatment targets in a prospective study.